SEC Form 4 · accession 0001127602-18-002589
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 12:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 24, 2018 | A | 6,511 | $0.00 | A | 18,182 | D | |
| Common Stock | Jan 24, 2018 | F | 2,872 | $106.97 | D | 15,310 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 27, 2015.